Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.

作者: Shuping Zhang , Xing Ke , Suyun Zeng , Meng Wu , Jianfang Lou

DOI: 10.1038/CMI.2015.57

关键词:

摘要: Regulatory T (Treg) cells may participate in mediating a suppressive microenvironment that blunts successful anti-tumor immunotherapy. Recent studies show CD8+ Treg might impede effective immune responses to established tumors. However, there is limited research regarding ovarian cancer (OC) patients. Here, we investigated OC patients and their vitro induction. The immunohistochemistry of tumor-infiltrating lymphocytes revealed significant correlation between the intratumoral forkhead box p3 (Foxp3)+ intraepithelial stromal areas advanced tissues. We examined expression markers from peripheral blood fresh tumor tissues using flow cytometry. Our results indicated an increase cell subsets compared with those benign tumors healthy controls, including increased CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), Foxp3 decreased CD28 expression. To demonstrate whether could convert effector into suppressor cells, used transwell culturing system. Compared cultured alone, induced by coculture SK-OV-3/A2780 showed CTLA-4 In addition, vitro-induced inhibited naive CD4+ T-cell proliferation, which was partially mediated through TGF-β1 IFN-γ. study suggests were be vitro, way limit antitumor immunity evade surveillance.

参考文章(40)
Silvia Deaglio, Karen M Dwyer, Wenda Gao, David Friedman, Anny Usheva, Anna Erat, Jiang-Fan Chen, Keiichii Enjyoji, Joel Linden, Mohamed Oukka, Vijay K Kuchroo, Terry B Strom, Simon C Robson, None, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression Journal of Experimental Medicine. ,vol. 204, pp. 1257- 1265 ,(2007) , 10.1084/JEM.20062512
Andrea Facciabene, Gregory T. Motz, George Coukos, T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis Cancer Research. ,vol. 72, pp. 2162- 2171 ,(2012) , 10.1158/0008-5472.CAN-11-3687
WanJun Chen, Wenwen Jin, Neil Hardegen, Ke-jian Lei, Li Li, Nancy Marinos, George McGrady, Sharon M. Wahl, Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 Journal of Experimental Medicine. ,vol. 198, pp. 1875- 1886 ,(2003) , 10.1084/JEM.20030152
Daniela Luvero, Andrea Milani, Jonathan A. Ledermann, Treatment options in recurrent ovarian cancer: latest evidence and clinical potential Therapeutic Advances in Medical Oncology. ,vol. 6, pp. 229- 239 ,(2014) , 10.1177/1758834014544121
Refika Yigit, Leon F.A.G. Massuger, Carl G. Figdor, Ruurd Torensma, Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecologic Oncology. ,vol. 117, pp. 366- 372 ,(2010) , 10.1016/J.YGYNO.2010.01.019
Paul Salama, Michael Phillips, Fabienne Grieu, Melinda Morris, Nik Zeps, David Joseph, Cameron Platell, Barry Iacopetta, None, Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer Journal of Clinical Oncology. ,vol. 27, pp. 186- 192 ,(2009) , 10.1200/JCO.2008.18.7229
Yukiko Kiniwa, Yoshihiro Miyahara, Helen Y. Wang, Weiyi Peng, Guangyong Peng, Thomas M. Wheeler, Timothy C. Thompson, Lloyd J. Old, Rong-Fu Wang, CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer Clinical Cancer Research. ,vol. 13, pp. 6947- 6958 ,(2007) , 10.1158/1078-0432.CCR-07-0842
Lin Zhang, Jose R. Conejo-Garcia, Dionyssios Katsaros, Phyllis A. Gimotty, Marco Massobrio, Giorgia Regnani, Antonis Makrigiannakis, Heidi Gray, Katia Schlienger, Michael N. Liebman, Stephen C. Rubin, George Coukos, Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. The New England Journal of Medicine. ,vol. 348, pp. 203- 213 ,(2003) , 10.1056/NEJMOA020177
Diana A. Alvarez Arias, Hye-Jung Kim, Penghui Zhou, Tobias A.W. Holderried, Xuan Wang, Glenn Dranoff, Harvey Cantor, Disruption of CD8+ Treg Activity Results in Expansion of T Follicular Helper Cells and Enhanced Antitumor Immunity Cancer immunology research. ,vol. 2, pp. 207- 216 ,(2014) , 10.1158/2326-6066.CIR-13-0121